chr5-33954406-TG-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_016180.5(SLC45A2):c.986delC(p.Thr329fs) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. T329T) has been classified as Benign. Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Consequence
SLC45A2
NM_016180.5 frameshift
NM_016180.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.42
Genes affected
SLC45A2 (HGNC:16472): (solute carrier family 45 member 2) This gene encodes a transporter protein that mediates melanin synthesis. The protein is expressed in a high percentage of melanoma cell lines. Mutations in this gene are a cause of oculocutaneous albinism type 4, and polymorphisms in this gene are associated with variations in skin and hair color. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-33954406-TG-T is Pathogenic according to our data. Variant chr5-33954406-TG-T is described in ClinVar as [Pathogenic]. Clinvar id is 4500.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-33954406-TG-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC45A2 | NM_016180.5 | c.986delC | p.Thr329fs | frameshift_variant | 4/7 | ENST00000296589.9 | NP_057264.4 | |
SLC45A2 | NM_001012509.4 | c.986delC | p.Thr329fs | frameshift_variant | 4/6 | NP_001012527.2 | ||
SLC45A2 | NM_001297417.4 | c.660delC | p.Asp220fs | frameshift_variant | 3/4 | NP_001284346.2 | ||
SLC45A2 | XM_047417259.1 | c.746delC | p.Thr249fs | frameshift_variant | 4/7 | XP_047273215.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC45A2 | ENST00000296589.9 | c.986delC | p.Thr329fs | frameshift_variant | 4/7 | 1 | NM_016180.5 | ENSP00000296589.4 | ||
SLC45A2 | ENST00000382102.7 | c.986delC | p.Thr329fs | frameshift_variant | 4/6 | 1 | ENSP00000371534.3 | |||
SLC45A2 | ENST00000509381.1 | c.660delC | p.Asp220fs | frameshift_variant | 3/4 | 1 | ENSP00000421100.1 | |||
SLC45A2 | ENST00000510600.1 | c.461delC | p.Thr154fs | frameshift_variant | 3/5 | 3 | ENSP00000424010.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 37
GnomAD4 exome
Cov.:
37
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 14, 2024 | Observed in the homozygous state or in the presence of another SLC45A2 variant in individuals with oculocutaneous albinism in the literature (PMID: 28170084, 14722913); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 21677667, 14722913, 28976636, Moreno-Artero2022[paper], 28298193, 24096233, 36553465, 28170084) - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 20, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 16, 2014 | - - |
SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 10, 2024 | - - |
Oculocutaneous albinism type 4 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2004 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at